HEALTHY_LIVING_PHARMACY_L - Accounts

Company Registration No. 05098078 (England and Wales)
HEALTHY LIVING PHARMACY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017
PAGES FOR FILING WITH REGISTRAR
HEALTHY LIVING PHARMACY LIMITED
COMPANY INFORMATION
Directors
Mr M Chenery
Mr D Leakey
Secretary
Mrs J Chenery
Company number
05098078
Registered office
40 Reevy Road West
Buttershaw
Bradford
West Yorkshire
BD6 3LX
Accountants
Torevell Dent Limited
Centre of Excellence
Hope Park
Trevor Foster Way
Bradford
West Yorkshire
BD5 8HH
HEALTHY LIVING PHARMACY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
4 - 8
HEALTHY LIVING PHARMACY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2017
31 March 2017
- 1 -
2017
2016
Notes
£
£
£
£
Fixed assets
Goodwill
3
7,333
51,333
Tangible assets
4
132,140
143,423
139,473
194,756
Current assets
Stocks
50,224
73,700
Debtors
5
197,420
192,999
Cash at bank and in hand
3,525
4,179
251,169
270,878
Creditors: amounts falling due within one year
6
(167,867)
(198,196)
Net current assets
83,302
72,682
Total assets less current liabilities
222,775
267,438
Creditors: amounts falling due after more than one year
7
(74,734)
(96,891)
Net assets
148,041
170,547
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
147,941
170,447
Total equity
148,041
170,547

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

HEALTHY LIVING PHARMACY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2017
31 March 2017
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 5 October 2017 and are signed on its behalf by:
Mr D Leakey
Director
Company Registration No. 05098078
HEALTHY LIVING PHARMACY LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2017
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2015
100
162,507
162,607
Year ended 31 March 2016:
Profit and total comprehensive income for the year
-
39,940
39,940
Dividends
-
(32,000)
(32,000)
Balance at 31 March 2016
100
170,447
170,547
Year ended 31 March 2017:
Profit and total comprehensive income for the year
-
10,494
10,494
Dividends
-
(33,000)
(33,000)
Balance at 31 March 2017
100
147,941
148,041
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017
- 4 -
1
Accounting policies
Company information

Healthy Living Pharmacy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 40 Reevy Road West, Buttershaw, Bradford, West Yorkshire, BD6 3LX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
2% on cost
Land and buildings Leasehold
20% on cost
Fixtures, fittings & equipment
25% on reducing balance
Computer equipment
25% on cost
Motor vehicles
25% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 5 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax has not been provided in these accounts as the Directors consider the potential liability to be not material.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 18 (2016 - 18).

3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2016 and 31 March 2017
440,000
Amortisation and impairment
At 1 April 2016
388,667
Amortisation charged for the year
44,000
At 31 March 2017
432,667
Carrying amount
At 31 March 2017
7,333
At 31 March 2016
51,333
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2016
177,802
90,165
267,967
Additions
-
3,019
3,019
At 31 March 2017
177,802
93,184
270,986
Depreciation and impairment
At 1 April 2016
76,914
47,630
124,544
Depreciation charged in the year
2,593
11,709
14,302
At 31 March 2017
79,507
59,339
138,846
Carrying amount
At 31 March 2017
98,295
33,845
132,140
At 31 March 2016
100,889
42,534
143,423
5
Debtors
2017
2016
Amounts falling due within one year:
£
£
Trade debtors
158,627
168,839
Other debtors
38,793
24,160
197,420
192,999
6
Creditors: amounts falling due within one year
2017
2016
£
£
Bank loans and overdrafts
26,817
54,824
Trade creditors
129,633
124,215
Corporation tax
5,187
4,334
Other taxation and social security
1,533
2,958
Other creditors
4,697
11,865
167,867
198,196
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 8 -
7
Creditors: amounts falling due after more than one year
2017
2016
£
£
Bank loans and overdrafts
67,369
82,884
Other creditors
7,365
14,007
74,734
96,891

 

8
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary Shares of £1 each
100
100
2017-03-312016-04-01falseCCH SoftwareCCH Accounts Production 2017.200No description of principal activity050980782016-04-012017-03-3105098078bus:Director12016-04-012017-03-3105098078bus:Director22016-04-012017-03-3105098078bus:CompanySecretary12016-04-012017-03-3105098078bus:RegisteredOffice2016-04-012017-03-31050980782017-03-3105098078core:Goodwill2017-03-3105098078core:Goodwill2016-03-3105098078core:NetGoodwill2017-03-3105098078core:NetGoodwill2016-03-31050980782016-03-3105098078core:LandBuildings2017-03-3105098078core:OtherPropertyPlantEquipment2017-03-3105098078core:LandBuildings2016-03-3105098078core:OtherPropertyPlantEquipment2016-03-3105098078core:CurrentFinancialInstruments2017-03-3105098078core:CurrentFinancialInstruments2016-03-3105098078core:ShareCapital2017-03-3105098078core:ShareCapital2016-03-3105098078core:RetainedEarningsAccumulatedLosses2017-03-3105098078core:RetainedEarningsAccumulatedLosses2016-03-3105098078core:ShareCapitalcore:RestatedAmount2015-03-3105098078core:RetainedEarningsAccumulatedLossescore:RestatedAmount2015-03-3105098078core:RestatedAmount2015-03-31050980782015-04-012016-03-3105098078core:RetainedEarningsAccumulatedLosses2015-04-012016-03-3105098078core:Goodwill2016-04-012017-03-3105098078core:LandBuildingscore:OwnedOrFreeholdAssets2016-04-012017-03-3105098078core:LandBuildingscore:LeasedAssetsHeldAsLessee2016-04-012017-03-3105098078core:FurnitureFittings2016-04-012017-03-3105098078core:ComputerEquipment2016-04-012017-03-3105098078core:MotorVehicles2016-04-012017-03-3105098078core:NetGoodwill2016-03-3105098078core:NetGoodwill2016-04-012017-03-3105098078core:LandBuildings2016-03-3105098078core:OtherPropertyPlantEquipment2016-03-31050980782016-03-3105098078core:OtherPropertyPlantEquipment2016-04-012017-03-3105098078core:LandBuildings2016-04-012017-03-3105098078core:Non-currentFinancialInstruments2017-03-3105098078core:Non-currentFinancialInstruments2016-03-3105098078bus:PrivateLimitedCompanyLtd2016-04-012017-03-3105098078bus:FRS1022016-04-012017-03-3105098078bus:AuditExemptWithAccountantsReport2016-04-012017-03-3105098078bus:FullAccounts2016-04-012017-03-31xbrli:purexbrli:sharesiso4217:GBP